Harbin Pharmaceutical Group Co., Ltd.
Status: Publicly traded
Direct answer
Harbin Pharmaceutical Group Co., Ltd. is publicly traded on SHH under the ticker 600664.SS.
Harbin Pharmaceutical Group Co., Ltd. functions as a leading pharmaceutical company, overseeing the complete process from drug discovery and development to manufacturing and global sales. The firm's activities span both domestic Chinese markets and international territories. Its business structure is segmented into seven key areas: Antibiotics, Small-Molecule Drug Formulations, Over-the-Counter (OTC) and Health...
Can you invest in Harbin Pharmaceutical Group Co., Ltd.?
Yes. Harbin Pharmaceutical Group Co., Ltd. trades publicly on SHH as 600664.SS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Harbin Pharmaceutical Group Co., Ltd.
Detailed equity research is provided by MarketSnap.